04:37 PM EDT, 05/29/2024 (MT Newswires) -- James T Treace, Director, on May 28, 2024, executed a purchase for 50,000 shares in Treace Medical Concepts ( TMCI ) for $253,475. Following the Form 4 filing with the SEC, Treace has control over a total of 1,645,624 shares of the company, with 1,089,441 shares held directly and 556,183 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1630627/000095017024065984/xslF345X03/ownership.xml

Price: 5.0098, Change: +0.01, Percent Change: +0.20